A new plant-based drug delivery platform based on alkyl polyglucosides and β-sitosterol nanovesicles for topical delivery
Source abstract
Abstract
• Novel nanovesicles without animal-derived components have been developed. • These stable nanovesicles are formed by the self-assembly of β-sitosterol, lauryl glucoside and lauryl glucose carboxylate using the single-step DELOS methodology. • Tocopherol as a hydrophobic model molecule is efficiently loaded in the nanovesicles (49 ± 12 %) maintaining its antioxidant function. • This new nanovesicles are biocompatible with the skin, as evaluated in a 3D epidermal in vitro model. • They enhance the ex vivo skin permeation of a hydrophobic fluorescent probe in terms of time and depth through the epidermis. The finding of new vesicular systems is a challenging process that depends on different factors such as the components used, the interactions between them or the dispersant media. Our objective was to develop a new vesicular delivery system formed by self-assembly of β-Sitosterol (Sit), Lauryl Glucoside (LGL) and Lauryl Glucose Carboxylate (LGC) molecules, all plant-based, biodegradable and biocompatible components. Nanovesicles (NVs) with different molar ratios of Sit, LGL and LGC were prepared using a single step method named DELOS, and characterized by dynamic light scattering, cryo-electron microscopy and small-angle X-ray scattering. Antioxidant compound α-tocopherol (TCP) was integrated in the NVs showing their potential to nanoformulate hydrophobic payloads. Finally, in vitro biocompatibility assays with reconstructed human epidermis and ex vivo skin retention studies using multiphoton microscopy and NVs labelled with Nile Red (NR) were carried out. As a result of this work, a new platform of NVs has been obtained by the self-assembly of Sit, LGL and LGC, obtaining vesicular systems with tunable physicochemical properties in terms of size (130 – 220 nm), surface charge ((-70) – (-40) mV) and lamellarity (unilamellar and multilamellar vesicles), when the carbon chain of the alkyl polyglucoside was >12. The vesicles could efficiently integrate TCP, proving their potential role as delivery systems and maintaining its antioxidant activity after loading. Finally, they also showed biocompatibility with the skin and improved the permeability of the poorly water-soluble molecule NR in terms of time and depth through the epidermis. Overall, the results of this work point to the successful development of an attractive platform based on stable and homogeneous nanovesicles composed of plant-derived ingredients for topical delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Lipid Membrane Structure and Behavior · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Beyond molecules: Self-assembly of mesoscopic and macroscopic components10.1073/pnas.082065899 ↗
2. Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective10.1002/adfm.202203669 ↗
3. Advances and challenges of liposome assisted drug delivery10.3389/fphar.2015.00286 ↗
4. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape10.1080/10717544.2016.1177136 ↗
5. Chemical stability of liposomes: implications for their physical stability10.1016/0009-3084(93)90053-6 ↗
6. Stability aspects of liposomes
7. Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update10.1016/j.ijpharm.2022.122022 ↗
8. Do niosomes have a place in the field of drug delivery?10.1080/17425247.2019.1663821 ↗
9. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes10.4103/2277-9175.178781 ↗
10. Stability Studies on Piroxicam Encapsulated Niosomes10.2174/1567201811666140723115852 ↗
11. Stable nanovesicles formed by intrinsically planar bilayers10.1016/j.jcis.2022.10.104 ↗
12. Quaternary ammonium-based biomedical materials: State-of-the-art, toxicological aspects and antimicrobial resistance10.1016/j.progpolymsci.2017.03.001 ↗
13. Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol10.3390/medicines3040029 ↗
14. β-Sitosterol as a functional bioactive
15. Sensitive skin: Active ingredients on the spotlight10.1111/ics.12754 ↗
16. Alkyl Polyglucosides: An emerging class of sugar surfactants, in: Alkyl Polyglucosides - From Nat. -Origin Surfactants to Prospect
17. Effect of β-sitosterol on the curcumin-loaded liposomes: Vesicle characteristics, physicochemical stability, in vitro release and bioavailability10.1016/j.foodchem.2019.04.077 ↗
18. A β–Sitosterol Encapsulated Biocompatible Alginate/Chitosan Polymer Nanocomposite for the Treatment of Breast Cancer10.3390/pharmaceutics14081711 ↗
19. Synthesis and characterization of redox-sensitive heparin-β-sitosterol micelles: Their application as carriers for the pharmaceutical agent, doxorubicin, and investigation of their antimetastatic activities in vitro10.1016/j.msec.2017.03.052 ↗
20. Alkyl mono- and di-glucoside sugar vesicles as potential drug delivery vehicles: detecting drug release using fluorescence10.1039/C5RA09183G ↗
21. Preparation and In vitro Characterization of Alkyl Polyglucoside-Based Microemulsion for Topical Administration of Curcumin10.3390/pharmaceutics15051420 ↗
22. Formulation of solid lipid nanoparticles (SLN): The value of different alkyl polyglucoside surfactants10.1016/j.ijpharm.2014.08.008 ↗
23. Elucidating Structural Configuration of Lipid Assemblies for mRNA Delivery Systems10.1021/acsnano.4c00587 ↗
24. N. Ventosa, J. Veciana, S. Sala, M. Cano, Method for obtaining micro- and nano-disperse systems, EP1843836, US7754777, CA2566960, 2006.
25. Preparation of uniform rich cholesterol unilamellar nanovesicles using CO2-expanded solvents10.1021/la7032109 ↗
26. Multifunctional nanovesicle-bioactive conjugates prepared by a one-step scalable method using CO2-expanded solvents10.1021/nl4017072 ↗
27. Liposomes: Advancements and innovation in the manufacturing process10.1016/j.addr.2020.07.002 ↗
28. Influence of the preparation route on the supramolecular organization of lipids in a vesicular system10.1021/ja2086678 ↗
29. Nanostructuring Lipophilic Dyes in Water Using Stable Vesicles, Quatsomes, as Scaffolds and Their Use as Probes for Bioimaging10.1002/smll.201703851 ↗
30. Measurement and interpretation of electrokinetic phenomena: (IUPAC technical report)10.1351/pac200577101753 ↗
31. Impact of chemical composition on the nanostructure and biological activity of α‑galactosidase‑loaded nanovesicles for Fabry disease treatment10.1021/acsami.0c16871 ↗
32. Structural information from multilamellar liposomes at full hydration: Full q-range fitting with high quality X-ray data10.1103/PhysRevE.62.4000 ↗
33. Hosemann · 1962
34. Guinier · 1963
35. Non-equilibrium micelles formed by sugar-based surfactants under their Krafft temperature10.1016/j.colsurfa.2017.12.053 ↗
36. Evaluation of the methods for determination of free radical scavenging activity by DPPH
37. 2021
38. Improvement of imiquimod solubilization and skin retention via tpgs micelles: Exploiting the co-solubilizing effect of oleic acid10.3390/pharmaceutics13091476 ↗
39. Cholesterol induced CTAB micelle-to-vesicle phase transitions10.1016/j.jcis.2010.04.069 ↗
40. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: Evaluation of physico-chemical and biological properties10.1016/j.ijpharm.2013.09.011 ↗
41. Colloidal stability of liposomes10.3934/matersci.2019.2.200 ↗
42. Quatsomes: Vesicles formed by self-assembly of sterols and quaternary ammonium surfactants10.1021/la4003803 ↗
43. Vesicles and Liposomes: A Self-Assembly Principle Beyond Lipids10.1002/adma.200300010 ↗
44. Thermodynamics and kinetics of vesicles formation processes10.1016/j.cis.2009.11.004 ↗
45. Vitamin E in dermatology10.4103/2229-5178.185494 ↗
46. Genesis and development of DPPH method of antioxidant assay10.1007/s13197-011-0251-1 ↗
47. E. Elizondo, E. Moreno, I. Cabrera, A. Córdoba, S. Sala, J. Veciana, N. Ventosa, Liposomes and other vesicular systems: Structural characteristics, methods of preparation, and use in nanomedicine, 2011. https://doi.org/10.1016/B978-0-12-416020-0.00001-2.10.1016/B978-0-12-416020-0.00001-2 ↗
48. Lipid-based nanovesicles for nanomedicine10.1039/C6CS00409A ↗
49. Liposome: Classification, preparation, and applications10.1186/1556-276X-8-102 ↗
50. Drug encapsulation and release from multilamellar and unilamellar liposomes10.1016/0378-5173(92)90015-T ↗
51. Controlling lamellarity and physicochemical properties of liposomes prepared using a microfluidic device10.1039/D2BM01703B ↗
52. Effect of preparation techniques on the properties of curcumin liposomes: Characterization of size, release and cytotoxicity on a squamous oral carcinoma cell line10.3109/10837450.2010.522583 ↗
53. Alkyl Polyglucoside-based delivery systems: In vitro/in vivo skin absorption assessment
54. Objective skin performance evaluation: How mild are APGs to the skin?
55. Deep tissue two-photon microscopy10.1038/nmeth818 ↗
56. Hyaluronic acid – PVA films for the simultaneous delivery of dexamethasone and levofloxacin to ocular tissues10.1016/j.ijpharm.2023.122911 ↗
57. Cyclosporine-loaded micelles for ocular delivery: Investigating the penetration mechanisms10.1016/j.jconrel.2022.07.019 ↗
58. Buccal Permeation of Polysaccharide High Molecular Weight Compounds: Effect of Chemical Permeation Enhancers10.3390/pharmaceutics15010129 ↗
59. Polar dyes in solution: A joint experimental and theoretical study of absorption and emission band shapes10.1021/jp020031b ↗
60. Liposome surface charge influence on skin penetration behaviour10.1016/j.ijpharm.2011.03.049 ↗
61. Liposomes as carriers for dermal delivery of tretinoin: In vitro evaluation of drug permeation and vesicle-skin interaction10.1016/j.jconrel.2004.11.020 ↗
62. Effect of positively and negatively charged liposomes on skin permeation of drugs10.3109/10611860108995632 ↗
63. The Scientific Committee on Consumer Safety's (SCCS) notes of guidance for the testing of cosmetics substances and their safety evaluation 8th revision